Author:
Markowska Agnieszka,Różański Andrzej,Wołczyński Sławomir,Midura-Nowaczek Krystyna
Subject
Drug Discovery,Pharmaceutical Science
Reference19 articles.
1. New developments in the use of nitrogen mustard alkylating agents as anticancer drugs;Denny,1998
2. W.A. Denny, Hypoxia-selective cytotoxins, in: W.O. Foye (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, 1995, pp. 483–500.
3. Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy;Friedlos;J. Med. Chem.,1997
4. Reductive chemistry of novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitro-benzamide;Palmer;J. Med. Chem.,1995
5. Hypoxia-selective antitumor agents. 9. Structure–activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide;Palmer;J. Med. Chem.,1994
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献